| Aditya Birla Sun Life Pharma & Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | - | ||||
| Rating | ||||||
| Growth Option 13-11-2026 | ||||||
| NAV | ₹36.94(R) | -0.24% | ₹41.26(D) | -0.24% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 18.09% | 19.13% | 13.92% | 20.08% | -% |
| Direct | 19.66% | 20.71% | 15.52% | 21.88% | -% | |
| Benchmark | ||||||
| SIP (XIRR) | Regular | 25.17% | 14.88% | 18.19% | 17.45% | -% |
| Direct | 26.77% | 16.38% | 19.78% | 19.1% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| 1.01 | 0.54 | 0.89 | 0.22% | 0.18 | ||
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| 15.74% | -16.54% | -15.36% | 0.93 | 11.05% | ||
| Fund AUM | As on: 30/12/2025 | 846 Cr | ||||
NAV Date: 13-11-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW | 24.39 |
-0.0600
|
-0.2500%
|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW | 26.83 |
-0.0600
|
-0.2200%
|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 36.94 |
-0.0900
|
-0.2400%
|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | 41.26 |
-0.1000
|
-0.2400%
|
Review Date: 13-11-2026
Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 6.89 | 9.46 |
7.81
|
4.58 | 9.94 | 12 | 17 | Average |
| 3M Return % | 0.46 | 6.96 |
3.01
|
-0.42 | 8.08 | 16 | 17 | Poor |
| 6M Return % | 12.66 | 19.86 |
15.30
|
7.74 | 22.44 | 14 | 17 | Average |
| 1Y Return % | 18.09 | 26.54 |
20.09
|
8.89 | 32.15 | 11 | 16 | Average |
| 3Y Return % | 19.13 | 23.39 |
21.29
|
17.27 | 29.74 | 9 | 11 | Average |
| 5Y Return % | 13.92 | 16.20 |
15.49
|
13.70 | 19.03 | 6 | 8 | Average |
| 7Y Return % | 20.08 | 21.54 |
22.92
|
20.08 | 24.83 | 8 | 8 | Poor |
| 1Y SIP Return % | 25.17 |
30.66
|
15.89 | 46.07 | 12 | 16 | Average | |
| 3Y SIP Return % | 14.88 |
16.31
|
10.76 | 25.88 | 6 | 11 | Good | |
| 5Y SIP Return % | 18.19 |
19.21
|
15.98 | 22.82 | 6 | 8 | Average | |
| 7Y SIP Return % | 17.45 |
19.13
|
16.73 | 21.95 | 7 | 8 | Poor | |
| Standard Deviation | 15.74 |
15.95
|
14.65 | 16.87 | 4 | 8 | Good | |
| Semi Deviation | 11.05 |
11.39
|
10.68 | 12.13 | 3 | 8 | Good | |
| Max Drawdown % | -15.36 |
-14.76
|
-16.36 | -12.33 | 6 | 8 | Average | |
| VaR 1 Y % | -16.54 |
-18.95
|
-23.32 | -15.67 | 2 | 8 | Very Good | |
| Average Drawdown % | 6.79 |
5.47
|
3.66 | 6.79 | 1 | 8 | Very Good | |
| Sharpe Ratio | 1.01 |
1.04
|
0.87 | 1.20 | 5 | 8 | Average | |
| Sterling Ratio | 0.89 |
0.94
|
0.81 | 1.09 | 6 | 8 | Average | |
| Sortino Ratio | 0.54 |
0.54
|
0.44 | 0.63 | 5 | 8 | Average | |
| Jensen Alpha % | 0.22 |
1.66
|
-0.46 | 3.84 | 6 | 8 | Average | |
| Treynor Ratio | 0.18 |
0.20
|
0.16 | 0.23 | 6 | 8 | Average | |
| Modigliani Square Measure % | 16.61 |
17.20
|
14.35 | 19.86 | 5 | 8 | Average | |
| Alpha % | -1.16 |
0.06
|
-1.73 | 3.02 | 6 | 8 | Average |
| KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 7.00 | 9.46 | 7.93 | 4.72 | 10.03 | 12 | 17 | Average |
| 3M Return % | 0.76 | 6.96 | 3.35 | -0.07 | 8.50 | 16 | 17 | Poor |
| 6M Return % | 13.35 | 19.86 | 16.07 | 8.14 | 23.38 | 14 | 17 | Average |
| 1Y Return % | 19.66 | 26.54 | 21.71 | 9.79 | 34.24 | 11 | 16 | Average |
| 3Y Return % | 20.71 | 23.39 | 22.77 | 18.56 | 31.28 | 9 | 11 | Average |
| 5Y Return % | 15.52 | 16.20 | 16.87 | 14.80 | 20.28 | 6 | 8 | Average |
| 7Y Return % | 21.88 | 21.54 | 24.44 | 21.88 | 26.49 | 8 | 8 | Poor |
| 1Y SIP Return % | 26.77 | 32.40 | 17.51 | 48.33 | 11 | 15 | Average | |
| 3Y SIP Return % | 16.38 | 18.00 | 12.38 | 27.33 | 6 | 10 | Good | |
| 5Y SIP Return % | 19.78 | 20.72 | 17.72 | 24.10 | 5 | 7 | Average | |
| 7Y SIP Return % | 19.10 | 20.54 | 18.50 | 23.23 | 5 | 7 | Average | |
| Standard Deviation | 15.74 | 15.95 | 14.65 | 16.87 | 4 | 8 | Good | |
| Semi Deviation | 11.05 | 11.39 | 10.68 | 12.13 | 3 | 8 | Good | |
| Max Drawdown % | -15.36 | -14.76 | -16.36 | -12.33 | 6 | 8 | Average | |
| VaR 1 Y % | -16.54 | -18.95 | -23.32 | -15.67 | 2 | 8 | Very Good | |
| Average Drawdown % | 6.79 | 5.47 | 3.66 | 6.79 | 1 | 8 | Very Good | |
| Sharpe Ratio | 1.01 | 1.04 | 0.87 | 1.20 | 5 | 8 | Average | |
| Sterling Ratio | 0.89 | 0.94 | 0.81 | 1.09 | 6 | 8 | Average | |
| Sortino Ratio | 0.54 | 0.54 | 0.44 | 0.63 | 5 | 8 | Average | |
| Jensen Alpha % | 0.22 | 1.66 | -0.46 | 3.84 | 6 | 8 | Average | |
| Treynor Ratio | 0.18 | 0.20 | 0.16 | 0.23 | 6 | 8 | Average | |
| Modigliani Square Measure % | 16.61 | 17.20 | 14.35 | 19.86 | 5 | 8 | Average | |
| Alpha % | -1.16 | 0.06 | -1.73 | 3.02 | 6 | 8 | Average |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Aditya Birla Sun Life Pharma & Healthcare Fund NAV Regular Growth | Aditya Birla Sun Life Pharma & Healthcare Fund NAV Direct Growth |
|---|---|---|
| 13-11-2026 | 36.94 | 41.26 |
| 12-11-2026 | 37.03 | 41.36 |
| 11-11-2026 | 37.17 | 41.51 |
| 09-11-2026 | 37.2 | 41.55 |
| 06-11-2026 | 36.5 | 40.76 |
| 05-11-2026 | 36.16 | 40.39 |
| 04-11-2026 | 36.04 | 40.25 |
| 03-11-2026 | 35.46 | 39.6 |
| 02-11-2026 | 35.21 | 39.32 |
| 30-10-2026 | 35.18 | 39.28 |
| 29-10-2026 | 34.97 | 39.05 |
| 28-10-2026 | 34.88 | 38.94 |
| 27-10-2026 | 34.51 | 38.52 |
| 26-10-2026 | 33.83 | 37.76 |
| 23-10-2026 | 33.4 | 37.28 |
| 22-10-2026 | 33.6 | 37.51 |
| 21-10-2026 | 33.54 | 37.44 |
| 19-10-2026 | 33.7 | 37.61 |
| 16-10-2026 | 34.06 | 38.01 |
| 15-10-2026 | 34.23 | 38.2 |
| 14-10-2026 | 34.29 | 38.26 |
| 13-10-2026 | 34.56 | 38.56 |
| Fund Launch Date: 11/Jul/2019 |
| Fund Category: Pharma Fund |
| Investment Objective: The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/ indicate any returns. There can be no assurance that the schemes’ objectives will be achieved. |
| Fund Description: An open ended equity scheme investing in Pharma and Healthcare Services Sector |
| Fund Benchmark: S&P BSE Healthcare Total Return Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.